Healthcare provider profile · identity verified

Darin Skaudis, MD

Internal Medicine · GRAND RAPIDS, MN · NPI 1396908521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	779	231
Amlodipine Besylate	Amlodipine Besylate	484	145
Metoprolol Succinate	Metoprolol Succinate	428	132
Levothyroxine Sodium	Levothyroxine Sodium	422	108
Lisinopril	Lisinopril	358	106
Losartan Potassium	Losartan Potassium	341	103
Gabapentin	Gabapentin	274	80
Metformin Hcl	Metformin Hcl	261	78
Omeprazole	Omeprazole	254	89
Tamsulosin Hcl	Tamsulosin Hcl	227	76
Rosuvastatin Calcium	Rosuvastatin Calcium	220	80
Famotidine	Famotidine	181	54
Allopurinol	Allopurinol	165	44
Furosemide	Furosemide	164	62
Montelukast Sodium	Montelukast Sodium	158	48
Simvastatin	Simvastatin	157	56
Metoprolol Tartrate	Metoprolol Tartrate	152	40
Pravastatin Sodium	Pravastatin Sodium	144	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	142	26
Carvedilol	Carvedilol	140	42
Jardiance	Empagliflozin	132	42
Tramadol Hcl	Tramadol Hcl	132	22
Eliquis	Apixaban	131	38
Spironolactone	Spironolactone	129	49
Potassium Chloride	Potassium Chloride	127	42
Jantoven	Warfarin Sodium	125	18
Donepezil Hcl	Donepezil Hcl	123	38
Pantoprazole Sodium	Pantoprazole Sodium	119	39
Clopidogrel	Clopidogrel Bisulfate	117	40
Metformin Hcl Er	Metformin Hcl	110	34
Lorazepam	Lorazepam	108	22
Oxycodone Hcl	Oxycodone Hcl	108	15
Duloxetine Hcl	Duloxetine Hcl	105	38
Hydrochlorothiazide	Hydrochlorothiazide	104	36
Escitalopram Oxalate	Escitalopram Oxalate	91	30
Sertraline Hcl	Sertraline Hcl	91	28
Glipizide	Glipizide	89	30
Torsemide	Torsemide	89	34
Irbesartan	Irbesartan	84	33
Prednisone	Prednisone	80	44
Trazodone Hcl	Trazodone Hcl	80	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	78	15
Zolpidem Tartrate	Zolpidem Tartrate	78	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	23
Venlafaxine Hcl Er	Venlafaxine Hcl	64	16
Azithromycin	Azithromycin	60	39
Glipizide Er	Glipizide	60	19
Paroxetine Hcl	Paroxetine Hcl	58	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	56	14
Warfarin Sodium	Warfarin Sodium	56	18
Citalopram Hbr	Citalopram Hydrobromide	55	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	24
Albuterol Sulfate Hfa	Albuterol Sulfate	53	26
Ozempic	Semaglutide	49	11
Pregabalin	Pregabalin	49	12
Sucralfate	Sucralfate	49	16
Bupropion Xl	Bupropion Hcl	48	17
Acetaminophen-Codeine	Acetaminophen With Codeine	47	12
Ventolin Hfa	Albuterol Sulfate	46	18
Clonazepam	Clonazepam	45	11
Atenolol	Atenolol	43	18
Doxycycline Hyclate	Doxycycline Hyclate	42	39
Cephalexin	Cephalexin	40	37
Tizanidine Hcl	Tizanidine Hcl	40	15
Xarelto	Rivaroxaban	40	12
Celecoxib	Celecoxib	39	12
Ezetimibe	Ezetimibe	38	17
Glipizide-Metformin	Glipizide/Metformin Hcl	38	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Carbamazepine Er	Carbamazepine	37	11
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	36	36
Nitroglycerin	Nitroglycerin	36	31
Fluticasone Propionate	Fluticasone Propionate	34	22
Alprazolam	Alprazolam	32	suppressed
Entresto	Sacubitril/Valsartan	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Baclofen	Baclofen	29	suppressed
Chlorthalidone	Chlorthalidone	29	11
Finasteride	Finasteride	29	12
Topiramate	Topiramate	29	suppressed
Amoxicillin	Amoxicillin	28	24
Methocarbamol	Methocarbamol	28	19
Ondansetron Odt	Ondansetron	28	15
Buprenorphine Hcl	Buprenorphine Hcl	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	26	26
Lovastatin	Lovastatin	26	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	20
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	24	suppressed
Dilt-Xr	Diltiazem Hcl	24	11
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Digoxin	Digoxin	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	23	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Oxycontin	Oxycodone Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Donepezil Hcl Odt	Donepezil Hcl	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Ibuprofen	Ibuprofen	20	12
Acyclovir	Acyclovir	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Dexamethasone	Dexamethasone	15	15
Guanfacine Hcl	Guanfacine Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Colchicine	Colchicine	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Nystatin	Nystatin	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error